News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
126,387 Results
Type
Article (12728)
Company Profile (17)
Press Release (113642)
Section
Business (25025)
Career Advice (68)
Deals (3983)
Drug Delivery (18)
Drug Development (23898)
Employer Resources (12)
FDA (5996)
Job Trends (2886)
News (59437)
Policy (6631)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (1)
2024 Bio NC Digital (2)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (1)
2024 Genetown Digital (1)
2024 Genetown Standard (2)
2024 Pharm Country Standard (2)
Academia (735)
Adcomms (8)
Allergies (16)
Alliances (8219)
ALS (31)
Alzheimer's disease (449)
Antibody-drug conjugate (ADC) (14)
Approvals (6009)
Artificial intelligence (23)
Autoimmune disease (5)
Automation (3)
Bankruptcy (32)
Best Places to Work (2714)
BIOSECURE Act (1)
Biosimilars (25)
Biotechnology (14)
Bladder cancer (6)
Brain cancer (14)
Breast cancer (59)
Cancer (505)
Cardiovascular disease (56)
Career advice (62)
Career pathing (2)
CAR-T (48)
Cell therapy (125)
Cervical cancer (4)
Clinical research (19647)
Collaboration (136)
Compensation (17)
Complete response letters (6)
COVID-19 (628)
CRISPR (6)
C-suite (20)
Cystic fibrosis (8)
Data (564)
Depression (8)
Diabetes (104)
Diagnostics (2386)
Digital health (4)
Diversity, equity & inclusion (2)
Drug discovery (24)
Drug pricing (14)
Drug shortages (3)
Duchenne muscular dystrophy (7)
Earnings (9669)
Editorial (3)
Employer branding (4)
Employer resources (11)
Events (15147)
Executive appointments (56)
FDA (6277)
Featured Employer (5)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (109)
Gene editing (21)
Generative AI (2)
Gene therapy (75)
GLP-1 (256)
Government (995)
Grass and pollen (2)
Guidances (5)
Healthcare (3495)
Huntington's disease (9)
IgA nephropathy (10)
Immunology and inflammation (22)
Indications (10)
Infectious disease (637)
Inflammatory bowel disease (26)
Inflation Reduction Act (1)
Influenza (2)
Intellectual property (9)
Interviews (4)
IPO (1683)
IRA (5)
Job creations (339)
Job search strategy (58)
Kidney cancer (3)
Layoffs (61)
Legal (852)
Liver cancer (21)
Lung cancer (61)
Lymphoma (74)
Management (4)
Manufacturing (34)
MASH (8)
Medical device (2892)
Medtech (2894)
Mergers & acquisitions (2350)
Metabolic disorders (191)
Multiple sclerosis (21)
NASH (2)
Neurodegenerative disease (25)
Neuropsychiatric disorders (5)
Neuroscience (580)
NextGen: Class of 2025 (943)
Non-profit (1035)
Northern California (435)
Now hiring (1)
Obesity (90)
Opinion (31)
Ovarian cancer (11)
Pain (17)
Pancreatic cancer (21)
Parkinson's disease (26)
Partnered (2)
Patents (36)
Patient recruitment (31)
Peanut (9)
People (5779)
Pharmaceutical (3)
Pharmacy benefit managers (3)
Phase I (5841)
Phase II (8010)
Phase III (7043)
Pipeline (188)
Podcasts (4)
Policy (9)
Postmarket research (1206)
Preclinical (2168)
Press Release (6)
Prostate cancer (30)
Psychedelics (3)
Radiopharmaceuticals (28)
Rare diseases (107)
Real estate (489)
Recruiting (3)
Regulatory (5313)
Reports (8)
Research institute (728)
Resumes & cover letters (6)
RNA editing (1)
Schizophrenia (12)
Series A (17)
Series B (10)
Service/supplier (1)
Sickle cell disease (35)
Southern California (319)
Sponsored (5)
Startups (511)
Stomach cancer (1)
Supply chain (8)
The Weekly (4)
United States (3595)
Vaccines (107)
Venture capitalists (1)
Webinars (2)
Weight loss (58)
Women's health (5)
Date
Today (39)
Last 7 days (154)
Last 30 days (541)
Last 365 days (7006)
2025 (1052)
2024 (7125)
2023 (7900)
2022 (10867)
2021 (11167)
2020 (10579)
2019 (8242)
2018 (6456)
2017 (6769)
2016 (6616)
2015 (7837)
2014 (5542)
2013 (4405)
2012 (4547)
2011 (4573)
2010 (4151)
Location
Africa (85)
Alabama (7)
Arizona (28)
Arkansas (5)
Asia (7147)
Australia (1510)
California (899)
Canada (317)
China (55)
Colorado (43)
Connecticut (35)
Delaware (25)
Europe (17312)
Florida (125)
Georgia (25)
Idaho (14)
Illinois (94)
India (3)
Indiana (57)
Iowa (2)
Japan (32)
Kansas (14)
Kentucky (3)
Louisiana (1)
Maine (7)
Maryland (155)
Massachusetts (691)
Michigan (16)
Minnesota (78)
Mississippi (1)
Missouri (23)
Montana (1)
Nebraska (4)
Nevada (11)
New Hampshire (7)
New Jersey (388)
New Mexico (4)
New York (270)
North Carolina (130)
North Dakota (1)
Northern California (435)
Ohio (19)
Oregon (4)
Pennsylvania (198)
Puerto Rico (1)
Rhode Island (1)
South America (149)
South Carolina (1)
Southern California (319)
Tennessee (32)
Texas (143)
Utah (28)
Virginia (17)
Washington D.C. (12)
Washington State (80)
Wisconsin (10)
126,387 Results for "cord blood registry".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Business
Cord Blood Registry® (CBR®) by CooperSurgical® and Fulgent Genetics Launch Innovative Genetic Testing
CooperSurgical today announced that they have partnered to offer families of Cord Blood Registry® (CBR®) exclusive newborn genetic screening panels.
February 9, 2024
·
6 min read
Pharm Country
Cord Blood Registry® Announces Thought Leadership Role at Cord Blood Connect
CooperSurgical, a global leader in fertility and women’s health, announced that Cord Blood Registry® will have a key role in the upcoming Cord Blood Connect meeting from September 8th – 11th, which is the annual meeting of the Cord Blood Association.
September 8, 2023
·
6 min read
Press Releases
Cord Blood Banking Services Market Size to Surge $65.36 Bn at 6.15% CAGR by 2034
January 21, 2025
·
1 min read
Press Releases
VectorBuilder Powers FDA IND Approval of World’s First Umbilical Cord Blood-Derived Allogeneic CAR-T Product
January 29, 2025
·
4 min read
Press Releases
U.S. FDA Approves StemCyte Biologics License Application for REGENECYTE™ Cord Blood Cell Therapy Product
November 22, 2024
·
2 min read
Pharm Country
Americord Releases Cord Blood Stem Cells for Treatment of Motor Neuron Disease
Americord, a leading private stem cell bank, announced the release of cord blood stem cells to a client’s grandmother in India for the treatment of motor neuron disease.
February 23, 2024
·
2 min read
Press Releases
CytoMed Therapeutics completes cash acquisition of Cord Blood Banking Licence and Assets expanding CytoMed’s strategy to cord blood-derived biologics through subsidiary, LongevityBank
October 3, 2024
·
5 min read
Business
Cord Blood Banking Leader Cryo-Cell Reports Fiscal First Quarter 2024 Financial Results
Cryo-Cell International, Inc. (NYSE American LLC: CCEL ) (the “Company”), the world’s first private cord blood bank to separate and store stem cells in 1992, announced results for the fiscal first quarter ended February 29, 2024.
April 15, 2024
·
6 min read
Press Releases
Cord Blood Banking Leader Cryo-Cell Declares Initiation of Regular Quarterly Cash Dividend
October 30, 2024
·
5 min read
Phase III
Takeda-Protagonist Drug for Incurable Cancer Reduces Need for Blood Withdrawals in Phase III Trial
Protagonist Therapeutics notches a milestone in its pact with Takeda for rusfertide. New data show that many patients with a chronic blood cancer taking the drug didn’t need to have their blood removed to bring down dangerously high hemocrit levels.
March 3, 2025
·
2 min read
·
Annalee Armstrong
1 of 12,639
Next
